[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
June 2015

Prolonged Lung Allograft Ischemia and Posttransplant Outcome

Author Affiliations
  • 1Division of Thoracic Surgery, Department of Surgery, Northwestern University School of Medicine, Chicago, Illinois
JAMA Surg. 2015;150(6):554. doi:10.1001/jamasurg.2015.0416

Mammalian cells do not possess intrinsic tolerance to hypoxia or ischemia. Hypothermia can suppress cellular metabolism and the chemical reactions that drive the detrimental effects of hypoxia and ischemia. However, hypothermia also nonspecifically inhibits vital enzymatic processes required for maintaining cellular integrity and tissue homeostasis. Therefore, reducing ischemia time and exposure to hypothermia during organ transplantation is desirable. The traditionally accepted upper limit for total ischemia in lung allografts is about 6 hours.1 Longer ischemia has been shown to decrease lung allograft function.2 Contrastingly, other studies,3 including the article by Grimm and colleagues,4 argue that prolonged ischemia more than 6 hours might not impact short- or long-term outcomes.

First Page Preview View Large
First page PDF preview
First page PDF preview